Novel immune-modulating formula versus standard formula for gastrointestinal cancer patients at risk of malnutrition undergoing surgery: A pilot randomized controlled trial.

Lakananurak N, Laosuwan P, Vongwattanakit P, Jittivasurat A, Techasukthavorn V

Open source

DOI
10.1016/j.clnesp.2026.102909
Published
2026 Apr
Container
Clinical nutrition ESPEN
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.clnesp.2026.102909,
  title = {Novel immune-modulating formula versus standard formula for gastrointestinal cancer patients at risk of malnutrition undergoing surgery: A pilot randomized controlled trial.},
  author = {Lakananurak N and Laosuwan P and Vongwattanakit P and Jittivasurat A and Techasukthavorn V},
  year = {2026},
  journal = {Clinical nutrition ESPEN},
  doi = {10.1016/j.clnesp.2026.102909},
  url = {https://doi.org/10.1016/j.clnesp.2026.102909}
}

RIS

TY  - JOUR
TI  - Novel immune-modulating formula versus standard formula for gastrointestinal cancer patients at risk of malnutrition undergoing surgery: A pilot randomized controlled trial.
AU  - Lakananurak N
AU  - Laosuwan P
AU  - Vongwattanakit P
AU  - Jittivasurat A
AU  - Techasukthavorn V
PY  - 2026
JO  - Clinical nutrition ESPEN
DO  - 10.1016/j.clnesp.2026.102909
UR  - https://doi.org/10.1016/j.clnesp.2026.102909
ER  - 

APA

N, L., P, L., P, V., A, J., & V, T. (2026). Novel immune-modulating formula versus standard formula for gastrointestinal cancer patients at risk of malnutrition undergoing surgery: A pilot randomized controlled trial.. Clinical nutrition ESPEN. https://doi.org/10.1016/j.clnesp.2026.102909

Source records